Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00018161 · ClinicalTrials.gov registry record · Phase 2
Treatment to Quit Smoking
A Phase 2 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00018161 is a Phase 2 study that has completed, run by US Department of Veterans Affairs.
The verdict
NCT00018161, a Phase 2 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This protocol evaluates the efficacy of combining pharmacologic treatments for smoking cessation, entailing the use of the nicotine skin patch with the nicotinic antagonist mecamylamine, with a specific behavioral therapy designed to inhibit the smoking urge.
Interventions
- DRUG Nicotine Patch
- DRUG Mecamylamine
- BEHAVIORAL Cigarette brand switching
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-01 |
| Est. Completion | 2001-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00018161
The ClinicalTrials.gov registry entry for NCT00018161 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine Patch is the first listed.
NCT00018161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00018161 about?
NCT00018161 is a clinical study titled "Treatment to Quit Smoking". This protocol evaluates the efficacy of combining pharmacologic treatments for smoking cessation, entailing the use of the nicotine skin patch with the nicotinic antagonist mecamylamine, with a specific behavioral therapy designed to inhibit the smoking urge.
What is the current status of trial NCT00018161?
This trial is currently completed. It is a Phase 2 study. The study started on 1997-01. Estimated completion is 2001-06.
What interventions are being tested in trial NCT00018161?
The interventions under investigation include: Nicotine Patch (DRUG), Mecamylamine (DRUG), Cigarette brand switching (BEHAVIORAL).
Who is sponsoring clinical trial NCT00018161?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.